Schwannoma | Meningioma | Neurofibroma | Myxopapillary Ependymoma
- Schwannoma vs Meningioma: Schwannoma is T2 hyperintense, meningioma is T2 iso/hypointense
- Dural tail sign: Suggestive of meningioma (contrast-enhancing dura adjacent to tumor)
- Dumbbell tumors: Neural foraminal extension, most commonly schwannoma (69%)
- Gross total resection: Curative for most benign IDEM tumors
- NF2 association: Multiple schwannomas/meningiomas, consider NF2 screening
- “T2 bright = schwannoma, T2 iso/dark = meningioma
- “Thoracic location + female = think meningioma
- “Dumbbell shape + cervical = think schwannoma
- “NF1 = neurofibromas, NF2 = schwannomas and meningiomas
Clinical Imaging
Imaging Atlas
Schwannoma: T2 hyperintense, may have cystic change, heterogeneous enhancement. Meningioma: T2 iso/hypointense, homogeneous enhancement, dural tail sign. Signal intensity ratio on T2 differentiates reliably.
Meningioma: 80% thoracic, lateral or posterolateral, 80% female. Schwannoma: Any level, often cervical/lumbar, equal gender. Ependymoma: Lumbar, filum terminale.
Neural foraminal extension creates dumbbell shape. Most common cause is schwannoma (69%). Consider stability if large extraforaminal component. May need combined anterior-posterior approach.
NF1 (von Recklinghausen): Neurofibromas, plexiform neurofibromas. NF2: Bilateral vestibular schwannomas PLUS spinal schwannomas/meningiomas. Multiple tumors = screen for NF2.
| Feature | Schwannoma | Meningioma |
|---|---|---|
| T2 Signal | HYPERINTENSE (bright) | Iso/HYPOINTENSE (dark) |
| Enhancement | Heterogeneous, may be cystic | Homogeneous |
| Dural tail | Absent/rare | Present (64%) |
| Location | Any level, cervical common | 80% thoracic |
| Gender | M = F | 80% female |
| Foraminal extension | Common (29%) | Rare (3%) |
| Cystic change | Common (96%) | Rare (24%) |
| Nerve root origin | Yes (displaced/encased) | No (dural origin) |
| Lesion | Compartment | Discriminating Features | Key Pitfall |
|---|---|---|---|
| Schwannoma | IDEM | T2 bright, cystic, foraminal extension, eccentric to root | Mistaking for neurofibroma when solitary |
| Meningioma | IDEM | T2 iso/dark, broad dural base, dural tail, thoracic, female | Calcified plaque mimicking bone lesion |
| Neurofibroma | IDEM | Target sign, nerve fibres pass through tumor, NF1, plexiform | Plexiform lesion harbouring MPNST |
| Myxopapillary ependymoma | IDEM (filum) | Filum terminale, sausage-shaped, mucin, may bleed | Piecemeal removal causing CSF seeding |
| Spinal cord ependymoma/astrocytoma | Intramedullary | Cord expansion, central location, syrinx | Calling an intramedullary tumor IDEM |
| Drop / leptomeningeal metastasis | IDEM (multiple) | Multiple nodules, nerve-root coating, sugar-coating | Single deposit mimicking primary tumor |
| Spinal arachnoid/neurenteric cyst | IDEM | CSF signal, no enhancement, cord displacement | Cyst masquerading as cystic schwannoma |
| Metastasis/epidural abscess | Extradural | Bone destruction, epidural soft tissue, restricted diffusion (abscess) | Missing infection in a diabetic patient |
IDEMIDEM Tumors - By Frequency
Hook:SMNE - Schwannoma Most common, Neurofibromas with NF1, Ependymoma at filum
MRISchwannoma vs Meningioma MRI
Hook:SCHMD - Schwannoma is bright, Cystic, Heterogeneous; Meningioma is Dark with Dural tail
NF1NF1 vs NF2 Features
Hook:NF1 = Neurofibromas (type 1), NF2 = schwannomas times 2 (bilateral)
Overview and Epidemiology
Intradural extramedullary (IDEM) tumors are located within the dural sac but outside the spinal cord parenchyma. They account for 55-75% of all intradural spinal tumors and are predominantly benign.
Distribution of IDEM Tumors:
- Frequency
- 40%
- Peak Age
- 30-60
- Gender
- M = F
- Frequency
- 25%
- Peak Age
- 40-70
- Gender
- F more than M (4:1)
- Frequency
- 15%
- Peak Age
- 30-50
- Gender
- M = F
- Frequency
- 10%
- Peak Age
- 20-40
- Gender
- M more than F
- Frequency
- 10%
- Peak Age
- Variable
- Gender
- Variable
Key Epidemiological Points:
Meningiomas show strong female predominance (80%) and thoracic predilection. Schwannomas affect males and females equally and occur at any spinal level. Ependymomas of the filum terminale (myxopapillary type) are the most common primary tumor of the conus/cauda equina region.
If a patient presents with multiple schwannomas or meningiomas, screen for Neurofibromatosis Type 2. NF2 is characterized by bilateral vestibular schwannomas and multiple spinal tumors. Chromosome 22 mutation.
Pathophysiology
Tumor Origins
Nerve Sheath Origin
Schwannomas arise from Schwann cells of spinal nerve roots. They are encapsulated tumors that displace rather than infiltrate nerve fibers.
Histology:
- Antoni A areas: Cellular, organized palisading (Verocay bodies)
- Antoni B areas: Loose, myxoid, less cellular
- S-100 protein positive
Growth Pattern:
- Eccentric growth from nerve root
- Nerve fibers displaced around capsule
- Usually single nerve root involved
- Nerve can often be preserved at surgery
Malignant transformation is extremely rare in sporadic schwannomas but may occur in NF2.
Classification
Spinal Tumor Compartments
- Location
- Outside dura
- Common Tumors
- Metastases, primary bone tumors
- Location
- Inside dura, outside cord
- Common Tumors
- Schwannoma, meningioma, neurofibroma
- Location
- Within spinal cord
- Common Tumors
- Ependymoma, astrocytoma, hemangioblastoma
IDEM tumors displace the spinal cord rather than infiltrate it. This generally allows preservation of cord function with surgical resection.
Clinical Presentation
Presenting Symptoms
Pain (Most Common Initial Symptom):
- Localized back pain (70%)
- Radicular pain following nerve root distribution
- May precede neurological deficit by months to years
- Night pain common
Neurological Deficit:
- Sensory changes (numbness, paresthesias)
- Motor weakness (progressive)
- Bladder/bowel dysfunction (late)
- Gait disturbance
Tumor-Specific Presentations
Schwannoma:
- Radicular pain in dermatomal distribution
- May have sensory loss in affected root
- Motor weakness if motor root involved
Meningioma:
- Often presents with progressive myelopathy
- Gait disturbance, spasticity
- Brown-Sequard syndrome if lateral compression
- May have minimal radicular symptoms
Myxopapillary Ependymoma:
- Low back pain
- Cauda equina symptoms (bowel/bladder, saddle anesthesia)
- Often long history before diagnosis
Examination Findings
Upper Motor Neuron Signs (cord compression):
- Spasticity, hyperreflexia below lesion
- Positive Babinski
- Clonus
Lower Motor Neuron Signs (root compression):
- Weakness in myotomal distribution
- Hyporeflexia at affected level
- Muscle atrophy
Tumors of the lumbar spine may cause cauda equina syndrome with saddle anesthesia, urinary retention, and bilateral leg weakness. This is a surgical emergency requiring urgent decompression.
Investigations
MRI - Gold Standard
Standard Sequences
Essential for IDEM tumor assessment.
T1-Weighted:
- Tumors usually isointense to cord
- Defines anatomical relationships
- Pre-contrast baseline
T2-Weighted/STIR:
- Schwannoma: Hyperintense
- Meningioma: Iso/hypointense
- Key differentiating sequence
- Shows cord edema
Post-Gadolinium T1:
- All IDEM tumors enhance
- Schwannoma: Heterogeneous
- Meningioma: Homogeneous + dural tail
Additional: Whole spine MRI to exclude skip lesions or NF2.
Additional Investigations
CT Scan:
- Bone erosion (dumbbell tumors)
- Calcification (meningioma)
- Pre-operative planning
Blood Tests:
- Routine pre-operative workup
- Consider genetic testing if NF suspected
Management
Surgical Management
Standard Posterior Approach
Most IDEM tumors approached posteriorly.
Laminectomy vs Laminoplasty:
- Laminectomy: Standard approach
- Laminoplasty: May reduce post-laminectomy kyphosis
- Consider instrumented fusion if extensive laminectomy (3+ levels)
Technical Steps:
- Posterior midline incision
- Laminectomy/laminoplasty
- Durotomy (midline or paramedian)
- Tumor identification
- Microsurgical resection
- Watertight dural closure
- Bone replacement if laminoplasty
Intraoperative neurophysiological monitoring (SSEP, MEP) recommended.
Non-Surgical Management
Observation:
- Small, asymptomatic tumors
- Elderly or medically unfit patients
- Slow-growing tumors (serial MRI monitoring)
Radiation:
- Rarely used for benign IDEM tumors
- Consider for recurrent/incompletely resected meningioma
- SRS (stereotactic radiosurgery) for small recurrences
- Primary treatment if patient not surgical candidate
For schwannomas, the parent nerve root can often be preserved because the tumor displaces rather than infiltrates nerve fibers. For neurofibromas, nerve fibers pass through the tumor, and root sacrifice is often necessary for complete resection.
Complications
Surgical Complications
Early:
- CSF leak (most common, 5-10%)
- Wound infection
- New neurological deficit (2-5%)
- Hematoma
Late:
- Post-laminectomy kyphosis
- Tumor recurrence
- Chronic pain
- Arachnoiditis
CSF Leak Prevention
Intraoperative:
- Meticulous dural closure
- Dural grafting if primary closure not possible
- Fibrin sealant augmentation
- Watertight closure in layers
If CSF Leak Occurs:
- Wound care
- Lumbar drain (3-5 days)
- Re-exploration if conservative measures fail
Recurrence Rates
- GTR Recurrence
- Less than 5%
- STR Recurrence
- 30-40%
- GTR Recurrence
- 5-10%
- STR Recurrence
- 20-30%
- GTR Recurrence
- Variable
- STR Recurrence
- Higher with NF1
- GTR Recurrence
- Less than 10%
- STR Recurrence
- 50-70%
Evidence Base
T2 Signal Intensity Ratio Differentiates Schwannoma from Meningioma
- 20 schwannomas vs 20 meningiomas, pathology-proven IDEM tumors
- Tumor-to-fat T2 signal-intensity ratio significantly higher in schwannoma (p=0.002)
- Optimal SI-ratio cutoff 0.420 (sensitivity 80%, specificity 70-75%)
- Area under ROC curve 0.78 for both independent readers
Long-Term Outcome After Spinal Schwannoma Removal
- 187 surgically treated spinal schwannomas, median follow-up 12.9 years
- Life expectancy equivalent to the general population
- Late complications in 21%: arachnoiditis (6%), spinal deformity (6%), cystic myelopathy (2%)
- Residual local pain (46%) and radiating pain (43%) were the commonest late complaints
Spinal Meningiomas: Surgical Management and Outcome
- Single-institution series plus pooled review of 556 patients from six large series
- Spinal meningiomas can be completely resected in most cases
- Surgery associated with postoperative functional improvement
- Low recurrence rate after complete resection
Long-Term Outcome of Spinal Myxopapillary Ependymoma (Rare Cancer Network)
- 183 patients across MD Anderson and the Rare Cancer Network
- Estimated 10-year overall survival 92.4%; 10-year progression-free survival 61.2%
- Treatment failure in ~32%, predominantly local (27%) but distant spinal/brain relapse in 9-6%
- Extent of surgery and use of adjuvant radiotherapy were independent prognostic factors
Nerve Root Sacrifice for Foraminal/Dumbbell Nerve Sheath Tumors
- 26 foraminal/dumbbell benign nerve sheath tumors; involved root routinely sacrificed
- Gross total resection achieved in 84.6%
- Functional motor roots (C5-T1, L3-S1) involved in 14 cases
- Persistent new or worsened motor deficit in only 1/9 and 1/5 patients respectively at follow-up
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A 55-year-old woman presents with 6 months of progressive gait difficulty and band-like thoracic pain. MRI shows a T6-T7 intradural extramedullary mass that is isointense on T2, enhances homogeneously, and has a dural tail sign.”
“A 45-year-old man presents with right-sided neck pain and C6 radiculopathy. MRI shows a C5-C6 intradural extramedullary tumor that is T2 hyperintense with heterogeneous enhancement. There is foraminal extension with an extraspinal component.”
“A 28-year-old man presents with 18 months of low back pain and recent onset of urinary hesitancy. MRI shows a well-circumscribed L3-L4 intradural tumor arising from the filum terminale. It is T2 hyperintense with homogeneous enhancement.”
“A 32-year-old woman presents with progressive gait ataxia. MRI shows three intradural extramedullary tumors at C3, T6, and L2. She also reports hearing loss for 2 years.”
Management Algorithm
Schwannoma vs Meningioma
- Schwannoma: T2 BRIGHT, heterogeneous, cystic, foraminal extension
- Meningioma: T2 ISO/DARK, homogeneous, dural tail, thoracic
- Signal intensity ratio on T2 reliably differentiates
- Schwannoma = any level, Meningioma = 80% thoracic
Tumor Frequencies
- Schwannoma: 40% (most common)
- Meningioma: 25% (80% female)
- Neurofibroma: 15% (NF1 associated)
- Myxopapillary ependymoma: 10% (filum terminale)
Surgical Goals
- GTR is curative for most IDEM tumors
- Schwannoma: Nerve preservation often possible
- Meningioma: Simpson Grade II (GTR + dural excision)
- Ependymoma: EN BLOC essential (capsule violation = seeding)
Dumbbell Tumors
- 69% are schwannomas
- Eden Classification: I-III based on extension
- Combined approach may be needed
- Assess stability if facetectomy required
NF Association
- NF1: Neurofibromas, plexiform, cafe-au-lait, chr 17
- NF2: Schwannomas + meningiomas, bilateral VS, chr 22
- Multiple spinal tumors = screen for NF2
- NF2 requires multidisciplinary approach
Complications
- CSF leak most common (5-10%)
- Post-laminectomy kyphosis (consider fusion if 3+ levels)
- Recurrence: GTR less than 5-10%, STR 30-40%
- Neurological deficit rare with microsurgical technique
Controversies & Areas of Uncertainty
1. Laminectomy vs laminoplasty vs instrumented fusion. Whether laminoplasty or routine instrumentation reduces post-operative deformity remains unsettled. Most series reserve fusion for multilevel laminectomy (3 or more levels), the cervicothoracic/thoracolumbar junctions, pre-existing deformity, and paediatric patients in whom post-laminectomy kyphosis is far more common.
2. Nerve root sacrifice in nerve sheath tumors. Traditional teaching preserves the parent root; contemporary data (Vandenbulcke et al., 2023) suggest the involved root in foraminal/dumbbell tumors is frequently non-functional and can be sacrificed to achieve gross total resection with a low risk of clinically significant deficit. Intra-operative stimulation to confirm a non-eloquent root is the pragmatic compromise.
3. Extent of dural handling for meningioma. Simpson Grade I (dural excision and duraplasty) lowers recurrence versus Grade II (coagulation only) but raises the risk of CSF leak and cord injury when the dura is ventral. Many surgeons accept Grade II for ventral/ventrolateral thoracic meningiomas where aggressive dural resection is hazardous.
4. Role of radiosurgery. Stereotactic radiosurgery is increasingly used for residual/recurrent meningioma and schwannoma and for NF2 tumors, but long-term spinal cord tolerance data are limited; surgery remains first-line for symptomatic compressive lesions.
5. Surveillance versus treatment of small asymptomatic tumors. Incidental small IDEM tumors (especially in NF2) are often observed with serial MRI; growth rate and symptom development, rather than size alone, drive the decision to operate.
Guidelines, Registries & Global Practice
Global Epidemiology
IDEM tumors comprise roughly 55-75% of all intradural spinal tumors. Incidence of primary spinal tumours overall is about 0.5-2.5 per 100,000 person-years. Schwannoma and meningioma together account for the majority; spinal meningioma shows a 3:1 to 4:1 female predominance with a thoracic predilection, while nerve sheath tumours are evenly distributed by sex and across spinal levels. Myxopapillary ependymoma is the commonest tumour of the conus/filum and presents in young adults.
Society Guidance & Frameworks (side by side)
- Scope
- Histopathology
- Practical recommendation
- Grades schwannoma/meningioma/neurofibroma (Gr I), atypical meningioma (Gr II); myxopapillary ependymoma reclassified to WHO Grade 2
- Scope
- Meningioma
- Practical recommendation
- Surgery first-line for symptomatic lesions; radiotherapy for atypical/incompletely resected disease
- Scope
- Ependymoma
- Practical recommendation
- Maximal safe resection; adjuvant RT after subtotal resection or anaplastic histology
- Scope
- Suspected spinal tumour / cord compression
- Practical recommendation
- Urgent whole-spine MRI and specialist referral for new myelopathy or cauda equina features
- Scope
- NF2-related schwannomatosis
- Practical recommendation
- Coordinated genetics, audiology, ophthalmology; consider bevacizumab for progressive vestibular schwannoma
There is no single arthroplasty-style registry for IDEM tumours; outcome evidence derives from institutional series, the Rare Cancer Network (myxopapillary ependymoma) and national cancer/CNS-tumour registries (e.g. CBTRUS in the US) which inform incidence and survival rather than implant survival.
High- vs Limited-Resource Practice Variation
In well-resourced centres, microsurgery with the operating microscope, intra-operative neurophysiological monitoring (SSEP/MEP/D-wave), ultrasonic aspiration and ready access to MRI surveillance underpin gross total resection rates comparable to international centres of excellence. In limited-resource settings, delayed presentation with established myelopathy is common, monitoring may be unavailable, and emphasis shifts to timely decompression and watertight closure to limit CSF leak. Genetic testing and dedicated NF2/schwannomatosis multidisciplinary clinics are concentrated in tertiary referral networks; telemedicine and regional referral pathways help extend specialist input where local capacity is limited.
References
- Takashima H, Takebayashi T, Yoshimoto M, et al. Differentiating spinal intradural-extramedullary schwannoma from meningioma using MRI T2 weighted images. Br J Radiol. 2018;91(1092):20180262. doi:10.1259/bjr.20180262. PMID 30052467.
- Seppala MT, Haltia MJ, Sankila RJ, et al. Long-term outcome after removal of spinal schwannoma: a clinicopathological study of 187 cases. J Neurosurg. 1995;83(4):621-6. doi:10.3171/jns.1995.83.4.0621. PMID 7674010.
- Gottfried ON, Gluf W, Quinones-Hinojosa A, et al. Spinal meningiomas: surgical management and outcome. Neurosurg Focus. 2003;14(6):e2. doi:10.3171/foc.2003.14.6.2. PMID 15669787.
- Weber DC, Wang Y, Miller R, et al. Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro Oncol. 2015;17(4):588-95. doi:10.1093/neuonc/nou293. PMID 25301811.
- Vandenbulcke A, D'Onofrio GF, Capo G, et al. Sacrifice of involved nerve root during surgical resection of foraminal and/or dumbbell spinal neurinomas. Brain Sci. 2023;13(1):109. doi:10.3390/brainsci13010109. PMID 36672090.